Product development tailored to customer applications and collaboration with external research institutions
First written in FY2016. 19 of 26 entries say "Restated". Latest entry: FY2026.
13 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Based on the concept of “Egg × Something = Tamago Tech,” the company is strengthening R&D to apply the potential of chicken eggs, including not only liquid eggs but also eggshells and eggshell membranes, to various fields and create new value.」
In addition to developing liquid eggs tailored to customer applications, the company has expanded its R&D focus to new applications and value creation involving the entire chicken egg, including eggshells and eggshell membranes. R&D expenses total ¥218 million, and the R&D structure comprises 19 people. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the six-month interim consolidated accounting period amounted to ¥117 million. There were no material changes in the status of the Group’s R&D activities during the six-month interim consolidated accounting period.」
The company recorded ¥117 million in R&D expenses but continues to state that there were no material changes in the status of its R&D activities. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the six-month interim consolidated accounting period amounted to ¥82 million. There were no material changes in the status of the Group’s R&D activities during the six-month interim consolidated accounting period.」
The company recorded ¥82 million in R&D expenses but continues to state that there were no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「Research and development is conducted mainly by the R&D function of the Kanto Business Division and the Manufacturing Division. The team comprises 19 employees in total, including 3 in the R&D function of the Kanto Business Division and 16 in the Manufacturing Division, as well as several part-time employees who provide support. The company has strengthened collaboration with universities and other research institutions and has begun full-scale activities aimed at joint development. Specifically, as demand for pasteurized liquid eggs increases from a safety and security perspective, the company is focusing its R&D efforts on developing pasteurized liquid eggs with foaming properties equivalent to those of unpasteurized liquid eggs, as well as liquid eggs suited to customer applications. It has commercialized pasteurized egg whites for confectionery use and new processed egg products made with liquid eggs and sells them to several customers.」
The company has an R&D structure of 19 people and has commercialized and begun selling to customers processed products made with pasteurized egg whites for confectionery use and liquid eggs. R&D expenses total ¥178 million, and the company is also conducting research on the effective utilization of eggshells and other materials. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter amounted to ¥137 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」
The company recorded ¥137 million in R&D expenses but continues to state that there were no material changes in the status of its R&D activities. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter amounted to ¥98 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」
The company recorded ¥98 million in R&D expenses but continues to state that there were no material changes in the status of its R&D activities. - FY2024-Q1AdvancedAnnual report
「Processed-product sales increased 41.3% year on year to ¥216 million, mainly due to price revisions for boiled eggs, steamed-egg-custard bases and other products, as well as higher sales of egg-white protein.」
In the rollout of processed products tailored to customer applications, price revisions and higher sales of boiled eggs, steamed-egg-custard bases and egg-white protein lifted processed-product sales 41.3% year on year to ¥216 million. - FY2023-Q3AdvancedAnnual report
「Processed-product sales increased 58.1% year on year to ¥596 million, mainly due to higher sales of boiled eggs and egg-white protein, while sales of other products increased 21.4% to ¥527 million.」
In the rollout of processed products tailored to customer applications, sales of boiled eggs and egg-white protein increased, lifting processed-product sales 58.1% year on year to ¥596 million. - FY2023-Q1AdvancedAnnual report
「Processed-product sales increased 64.7% year on year to ¥152 million, mainly due to higher sales of boiled eggs and egg-white protein, while sales of other products increased 37.4% to ¥169 million.」
Sales of processed products such as boiled eggs and egg-white protein increased, lifting processed-product sales 64.7% year on year to ¥152 million. The company stated that there were no material changes in its R&D activities themselves. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter amounted to ¥69 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」
It recorded ¥69 million in research and development expenses and explains that there were no material changes in the status of research and development activities. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter amounted to ¥34 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
The company recorded ¥34 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2021AdvancedAnnual report
「The company commercialized new processed egg products made with pasteurized egg whites for confectionery use or liquid eggs and sells them to several customers.」
The company is commercializing and selling to customers pasteurized egg whites for confectionery use and new processed egg products tailored to customer applications. R&D expenses total ¥147 million, and the R&D structure comprises 16 people. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter amounted to ¥117 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」
The company recorded ¥117 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter amounted to ¥76 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」
The company recorded ¥76 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter amounted to ¥36 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
The company recorded ¥36 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter amounted to ¥104 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」
The company recorded ¥104 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter amounted to ¥71 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」
The company recorded ¥71 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter amounted to ¥31 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
The company recorded ¥31 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter amounted to ¥113 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」
The company recorded ¥113 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter amounted to ¥34 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
The company recorded ¥34 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2018RestatedAnnual report
「Research and development is conducted mainly by the R&D function of the Kanto Business Division and the Manufacturing Division. The team comprises 15 employees in total, including 4 in the R&D function of the Kanto Business Division, 2 in the Production Control Section of the Manufacturing Division, and 9 in its Quality Control Section, as well as several part-time employees who provide support. The company has strengthened collaboration with universities and other research institutions and has begun full-scale activities aimed at joint development.」
The company continues to maintain an R&D structure centered on 15 people, collaboration with universities and research institutions, and liquid-egg development tailored to customer applications. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter amounted to ¥110 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」
The company recorded ¥110 million in R&D expenses for the cumulative third quarter and stated that there were no material changes in its R&D activities. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter amounted to ¥74 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」
The company recorded ¥74 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter amounted to ¥36 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」
The company recorded ¥36 million in R&D expenses and stated that there were no material changes in the status of its R&D activities. - FY2017AdvancedAnnual report
「Research and development is conducted mainly by the R&D function of the Kanto Business Division and the Manufacturing Division. The team comprises 15 employees in total, including 3 in the R&D function of the Kanto Business Division, 3 in the Production Control Section of the Manufacturing Division, and 9 in its Quality Control Section, as well as several part-time employees who provide support. The company has strengthened collaboration with universities and other research institutions and has begun full-scale activities aimed at joint development. Specifically, as demand for pasteurized liquid eggs increases from a safety and security perspective, the company is focusing its R&D efforts on developing pasteurized liquid eggs with foaming properties equivalent to those of unpasteurized liquid eggs, as well as liquid eggs suited to customer applications. It has commercialized pasteurized egg whites for confectionery use and a steamed-egg-custard base made mainly from egg whites, and sells these products to several customers.」
The company stepped up joint development with universities and research institutions and, with an R&D structure centered on 15 people, commercialized pasteurized egg whites for confectionery use and a steamed-egg-custard base and began selling them to customers. - FY2016First statedAnnual report
「We also intend to collaborate with prefectural and national research institutions and universities to study potential new applications for chicken eggs and the effective utilization of waste.」
In addition to developing and improving the quality of liquid eggs, for which customer demand is high, the company is conducting research on joint development with universities and research institutions, new applications, and the effective utilization of waste. It states that products such as pasteurized egg whites for confectionery use have already been commercialized.